Aggressive characteristics of myeloblasts expressing CD7 in myelodysplastic syndromes-Reference-Cited by-同舟云学术

Aggressive characteristics of myeloblasts expressing CD7 in myelodysplastic syndromes

Published:2009-02 Issue:2 Volume:33 Page:326-331
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Satoh Chikako,Tamura Hideto,Yamashita Taishi,Tsuji Takashi,Dan Kazuo,Ogata Kiyoyuki

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference29 articles.

1. T cell signal transduction and the role of CD7 in costimulation;Stillwell;Immunol. Res.,2001

2. Triggering of co-mitogenic signals in T cell proliferation by anti-LFA-1 (CD18, CD11a), LFA-3, and CD7 monoclonal antibodies;Carrera;J. Immunol.,1988

3. Inhibition of lymphocyte proliferation by a monoclonal antibody (RFT2) against CD7;Costantinides;Clin. Exp. Immunol.,1991

4. Cross-linking CD7 on myeloblasts results in granulocyte-macrophage colony-stimulating factor production;Hou;Blood,1996

5. Reappraisal of the clinical significance of CD7 expression in association with cytogenetics in de novo acute myeloid leukaemia;Ogata;Br. J. Haematol.,2001

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the immunophenotypic landscape in acute myeloid leukemia: genotype-phenotype associations and predictive modeling of outcome;2023-10-12

2. Reliability of flow-cytometry in diagnosis and prognostic stratification of myelodysplastic syndromes: correlations with morphology and mutational profile;Annals of Hematology;2023-08-03

3. Targeted CD7 CAR T-cells for treatment of T-Lymphocyte leukemia and lymphoma and acute myeloid leukemia: recent advances;Frontiers in Immunology;2023-05-05

4. Differential effects of recombinant human thrombopoietin on clinical outcomes in CD7-positive and CD7-negative acute myeloid leukaemia;Leukemia Research;2023-05

5. CAR T-cell Therapy of Hematologic Malignancies: An Update in Targeted Antigens;Iranian Journal of Pediatric Hematology & Oncology;2023-03-28